Human Immunology News Volume 8.27 | July 14 2020

    0
    56







    HIN Volume 8.27 | Jul 14


    Human Immunology News by STEMCELL Technologies
    Vol. 8.27 – 14 July, 2020
    TOP STORY

    Metabolic Engineering Generates a Transgene-Free Safety Switch for Cell Therapy

    Using genome editing methods, scientists disrupted uridine monophosphate synthetase (UMPS) in the pyrimidine de novo synthesis pathway in cell lines, pluripotent cells and primary human T cells.
    [Nature Biotechnology]

    Abstract
    Subscribe to Science News for free weekly science newsletters.

    Humoral and Circulating Follicular Helper T Cell Responses in Recovered Patients with COVID-19

    Researchers found that S-specific antibodies, memory B cells and circulating follicular helper T cell were consistently elicited after SARS-CoV-2 infection, demarking robust humoral immunity and positively associated with plasma neutralizing activity.
    [Nature Medicine]

    Full Article

    Naproxen Chemoprevention Promotes Immune Activation in Lynch Syndrome Colorectal Mucosa

    Investigators conducted a Phase Ib, placebo-controlled, randomised clinical trial of two dose levels of naproxen sodium administered daily for six months to 80 participants with Lynch syndrome (LS), and a co-clinical trial using a genetically engineered mouse model of LS and patient-derived organoids
    [Gut]

    Full Article

    Cholesterol Metabolism Drives Regulatory B Cell IL-10 through Provision of Geranylgeranyl Pyrophosphate

    Researchers demonstrated that the induction of a regulatory program in human B cells was dependent on a metabolic priming event driven by cholesterol metabolism.
    [Nature Communications]

    Full Article

    LRRK 2 Activation Controls the Repair of Damaged Endomembranes in Macrophages

    Scientists showed that the Parkinson’s disease‐related kinase LRRK 2 was activated in macrophages by pathogen‐ or sterile‐induced endomembrane damage.
    [EMBO Journal]

    AbstractGraphical Abstract

    Cancer Cells Educate Natural Killer Cells to a Metastasis-Promoting Cell State

    Using ex vivo and in vivo models of metastasis, researchers established that keratin-14+ breast cancer cells were vulnerable to natural killer cells.
    [Journal of Cell Biology]

    Full Article

    Optimized Ex Vivo Stimulation Identifies Multi-Functional HBV-Specific T Cells in a Majority of Chronic Hepatitis B Patients

    Investigators modified the key variables of cell number and the peptide pulsing method to improve ex vivo detection of HBV-specific T cells.
    [Scientific Reports]

    Full Article

    The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy Is Dominated by Myeloid Cells

    Freshly resected prostate specimens were processed to obtain single-cell suspensions, and immune-phenotyped for major lymphoid and myeloid cell subsets by staining with two separate 14-antibody panels and multicolor flow cytometry analysis.
    [Prostate Cancer and Prostatic Diseases]

    Abstract

    AMG-232 Sensitizes High MDM2-Expressing Tumor Cells to T-Cell-Mediated Killing

    Ovarian clear cell carcinoma cell lines carrying wild-type p53 with low/high mouse double minute 2 homolog (MDM2) expression were investigated in a T-cell co-culture system evaluating T-cell-mediated tumor killing.
    [Cell Death Discovery]

    Full Article

    CD70 Expression Determines the Therapeutic Efficacy of Expanded Human Regulatory T Cells

    Scientists showed that after prolonged in vitro stimulation, a significant proportion of human regulatory T cells gained stable CD70 expression while losing CD27.
    [Communications Biology]

    Full Article

    Learn about immunological considerations for hPSC banking by watching Dr. David Turner's webinar from the Nature Research Round Table on hPSC Quality
    REVIEWS

    Immunotherapeutic Strategies in Pancreatic Ductal Adenocarcinoma (PDAC): Current Perspectives and Future Prospects

    The authors focus on existing and potential immune targets for PDAC, drugs used to target them, and some clinical trials conducted so far with them.
    [Molecular Biology Reports]

    Abstract

    INDUSTRY AND POLICY NEWS

    Foreign Students in US: Trump Administration Drops Deportation Plans

    US President Donald Trump’s government has dropped its plans to deport international students whose courses move fully online because of the coronavirus pandemic.
    [BBC]

    Editorial

    Journals Endorse New Checklist to Clean Up Sloppy Animal Research

    To address the problem of poor reporting, Percie du Sert and a team of researchers have developed a checklist of 10 critical details each animal study needs to report, such as the number of animals used, their sex, whether they were randomly allocated to a test group and control group, and whether the researchers knew which animal was in which group.
    [Science Insider]

    Editorial

    SOTIO Announces First Patient Dosed in Part B of Phase I/Ib Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors

    SOTIO announced that the first patient has been dosed in Part B of the ongoing Phase I/Ib study of IL-15 superagonist, SO-C101, for the treatment of patients with advanced/metastatic solid tumors. Part B will examine SO-C101 in combination with PD-1 inhibitor pembrolizumab. The trial is conducted in partnership with Cytune Pharma.
    [Sotio]

    Press Release

    FEATURED EVENT

    Allergy and Clinical Immunology Update 2020 – Save the Date!

    September 26
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Positions – Inflammatory Bowel Diseases and Tumor Immunology

    The University of Texas Southwestern Medical Center – Dallas, Texas, United States

    Program Head – Cell Therapy and Immuno-Oncology Development

    Lerner Research Institute – Cleveland, Ohio, United States

    Postdoctoral Researcher – Molecular Biology and Immunology

    University of California Los Angeles – Los Angeles, California, United States

    Research Scientist – SARS-CoV-2 Vaccine Development

    Ohio State University – Columbus, Ohio, United States

    Postdoctoral Fellow – Immunology

    H. Lee Moffitt Cancer Center & Research Institute – Tampa, Florida, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Human Immunology News Twitter